Paolo Gisondi (P Gisondi)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 132

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

The British journal of dermatology

Vaccines

Expert opinion on biological therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Giacomo Caldarola, Lorenzo Maria Pinto, Francesco Bellinato, Nicoletta Bernardini, Elena Campione, Andrea Chiricozzi, Laura Colonna, Clara De Simone, Laura Diluvio, Paolo Gisondi, Enrico Matteini, Eleonora Tomassetti, Ersilia Tolino, Luca Bianchi, Ketty Peris
Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment. Expert opinion on drug safety (2024)
Riccardo Viola, Luca Mastorino, Matteo Megna, Giovanni Damiani, Paolo Gisondi, Giuseppe Argenziano, Ketty Peris, Francesca Prignano, Martina Burlando, Andrea Conti, Francesco Loconsole, Piergiorgio Malagoli, Iris Zalaudek, Sara Cacciapuoti, Francesco Bellinato, Anna Balato, Clara De Simone, Karin Chersi, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort. International journal of dermatology (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Paolo Dapavo, Martina Burlando, Claudio Guarneri, Matteo Megna, Alessandra Narcisi, Marina Talamonti, Paolo Gisondi
Tildrakizumab: the value of a personalized and flexible approach for treating moderate-to-severe plaque psoriasis in patients with high body weight or high disease burden. Expert opinion on biological therapy (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology (2024)
Paolo Dapavo, Martina Burlando, Claudio Guarneri, Matteo Megna, Alessandra Narcisi, Marina Talamonti, Paolo Gisondi
Tildrakizumab: the value of a personalized and flexible approach for treating moderate-to-severe plaque psoriasis in patients with high body weight or high disease burden. Expert opinion on biological therapy 24 (3) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Andrea Spini, Giorgia Pellegrini, Ylenia Ingrasciotta, Luca L'Abbate, Chiara Bellitto, Massimo Carollo, Olivia Leoni, Martina Zanforlini, Domenica Ancona, Paolo Stella, Anna Cavazzana, Angela Scapin, Sara Lopes, Valeria Belleudi, Stefano Ledda, Paolo Carta, Paola Rossi, Lucian Ejlli, Ester Sapigni, Aurora Puccini, Stefania Spila Alegiani, Marco Massari, Claudio Guarneri, Paolo Gisondi, Gianluca Trifirò
Switching pattern of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network. Expert opinion on biological therapy (2024)
Paolo Gisondi, Tamara Gracia-Cazaña, Hjalmar Kurzen, Jordi Galván
Calcipotriol/Betamethasone Dipropionate for the Treatment of Psoriasis: Mechanism of Action and Evidence of Efficacy and Safety versus Topical Corticosteroids. Journal of clinical medicine 13 (15) (2024)
Andrea Spini, Giorgia Pellegrini, Ylenia Ingrasciotta, Luca L'Abbate, Chiara Bellitto, Massimo Carollo, Olivia Leoni, Martina Zanforlini, Domenica Ancona, Paolo Stella, Anna Cavazzana, Angela Scapin, Sara Lopes, Valeria Belleudi, Stefano Ledda, Paolo Carta, Paola Rossi, Lucian Ejlli, Ester Sapigni, Aurora Puccini, Stefania Spila Alegiani, Marco Massari, Claudio Guarneri, Paolo Gisondi, Gianluca Trifirò
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network. Expert opinion on biological therapy (2024)
Andrea Chiricozzi, Giulia Coscarella, Lluis L Puig, Ronald B Vender, Jensen Yeung, Y José Manuel Carrascosa, Stefano Piaserico, Paolo Gisondi, Charles Lynde, Paulo Ferreira, Pedro Mendes Bastos, Esteban Daudén, Luiz Leite, Joana Valerio, Elena Del Alcázar-Viladomiu, Eva Vilarrasa, Mar Llamas Velasco, Mario Alessandri-Bonetti, Francesco Messina, Manfredo Bruni, Eugenia Veronica Di Brizzi, Federica Ricceri, Alessia Nidegger, Jan Hugo, Asfandyar Mufti, Athina-Ioanna Daponte, Laetitia Teixeira, Anna Balato, Marco Romanelli, Francesca Prignano, Spyridon Gkalpakiotis, Curdin Conrad, Elizabeth Lazaridou, Natalia Rompoti, Alexander J Stratigos, Miguel Nogueira, Ketty Peris, Tiago Torres
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Paolo Dapavo, Martina Burlando, Claudio Guarneri, Matteo Megna, Alessandra Narcisi, Marina Talamonti, Paolo Gisondi
Tildrakizumab: the value of a personalized and flexible approach for treating moderate-to-severe plaque psoriasis in patients with high body weight or high disease burden. Expert opinion on biological therapy 24 (3) (2024)
Francesco Bellinato, Martina Maurelli, Davide Geat, Giampiero Girolomoni, Paolo Gisondi
Managing the Patient with Psoriasis and Metabolic Comorbidities. American journal of clinical dermatology 25 (4) (2024)
Andrea Spini, Giorgia Pellegrini, Ylenia Ingrasciotta, Luca L'Abbate, Chiara Bellitto, Massimo Carollo, Olivia Leoni, Martina Zanforlini, Domenica Ancona, Paolo Stella, Anna Cavazzana, Angela Scapin, Sara Lopes, Valeria Belleudi, Stefano Ledda, Paolo Carta, Paola Rossi, Lucian Ejlli, Ester Sapigni, Aurora Puccini, Stefania Spila Alegiani, Marco Massari, Claudio Guarneri, Paolo Gisondi, Gianluca Trifirò
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network. Expert opinion on biological therapy 24 (5) (2024)
Bianca Maria Piraccini, Francesca Pampaloni, Stephano Cedirian, F Quadrelli, Francesca Bruni, Luca Rapparini, Gemma Caro, M C Acri, L Ala, Alfredo Rossi, G Pellacani, Francesco Lacarrubba, G Micali, F Dall'Oglio, Marina Vastarella, M Cantelli, P Nappa, Laura Diluvio, L Bianchi, Laura Gnesotto, Andrea Sechi, L Naldi, F Tassone, K Peris, Giacomo Caldarola, L M Pinto, Giampiero Girolomoni, F Marangoni, Francesco Bellinato, Paolo Gisondi, I Scandagli, Francesca Prignano, N Pimpinelli, C Tomasini, Stefania Barruscotti, Edoardo De Simoni, O Simonetti, F Ambrogio, C Foti, V Boccaletti, A Fraghì, Angelo Valerio Marzano, M A Mattioli, L Rocca, M Barbareschi, S M Ferrucci, Giuseppe Gallo, Simone Ribero, Pietro Quaglino, R Balestri, T Ioris, R D Caposiena Caro, I Zalaudek, E Vagnozzi, Maria-Concetta Fargnoli, C Caponio, P Rubegni, Elisa Cinotti, Emanuele Trovato, M Romanelli, Valentina Dini, Flavia Manzo Margiotta, Claudio Feliciani, M B de Felici Del Giudice, Laura Atzori, S Sanna, S Lembo, Annunziata Raimondo, Michela Magnano, Michela Valeria Rita Starace
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Riccardo Viola, Luca Mastorino, Matteo Megna, Giovanni Damiani, Paolo Gisondi, Giuseppe Argenziano, Ketty Peris, Francesca Prignano, Martina Burlando, Andrea Conti, Francesco Loconsole, Piergiorgio Malagoli, Iris Zalaudek, Sara Cacciapuoti, Francesco Bellinato, Anna Balato, Clara De Simone, Karin Chersi, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort. International journal of dermatology 63 (3) (2024)
Gianluca Nazzaro, Andrea Carugno, Paolo Bortoluzzi, Stefano Buffon, Chiara Astrua, Elena Zappia, Emanuele Trovato, Stefano Caccavale, Vincenzo Pellegrino, Giovanni Paolino, Riccardo Balestri, Rossella Lacava, Giulia Ciccarese, Alice Verdelli, Stefania Barruscotti, Mario Valenti, Giulia Toni, Serena Giacalone, Elisa Zavattaro, Laura C Gironi, Santo R Mercuri, Simone Ribero, Paolo Gisondi, Paolo Sena, Angelo V Marzano
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients. International journal of dermatology (2024)
Paolo Gisondi, Tamara Gracia-Cazaña, Hjalmar Kurzen, Jordi Galván
Calcipotriol/Betamethasone Dipropionate for the Treatment of Psoriasis: Mechanism of Action and Evidence of Efficacy and Safety versus Topical Corticosteroids. Journal of clinical medicine 13 (15) (2024)
Riccardo Viola, Luca Mastorino, Matteo Megna, Giovanni Damiani, Paolo Gisondi, Giuseppe Argenziano, Ketty Peris, Francesca Prignano, Martina Burlando, Andrea Conti, Francesco Loconsole, Piergiorgio Malagoli, Iris Zalaudek, Sara Cacciapuoti, Francesco Bellinato, Anna Balato, Clara De Simone, Karin Chersi, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort. International journal of dermatology 63 (3) (2024)
Paolo Gisondi, David Simon, Ivette Alarcon, Effie Pournara, Lluis L Puig
Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients receiving secukinumab: a literature review. The Journal of dermatological treatment 34 (1) (2023)
Anna Balato, Francesca Ambrogio, Martina Burlando, Carlo Giovanni Carrera, Andrea Chiricozzi, Maria Esposito, Stefano Piaserico, Miriam Teoli, Paolo Gisondi
Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice. Dermatology and therapy (2023)
Alen Zabotti, Gabriele De Marco, Laure Gossec, Xenofon Baraliakos, Daniel Aletaha, AnnaMaria Iagnocco, Paolo Gisondi, Peter V Balint, Heidi Bertheussen, Wolf-Henning Boehncke, Nemanja S Damjanov, Maarten P T de Wit, Enzo Errichetti, Helena Marzo-Ortega, Mikhail Protopopov, Lluis Puig, Rubén Queiro, Roberto Caporali, Laura Savage, Larissa Valor-Méndez, Stefan Siebert, Tanja Alexandra Stamm, Paul Studenic, Ilaria Tinazzi, Filip E Van den Bosch, Annette van der Helm-van Mil, Giovanni Damiani, Josef S Smolen, Dennis G McGonagle
EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis. Annals of the rheumatic diseases (2023)
Paolo Gisondi, David Simon, Ivette Alarcon, Effie Pournara, Lluis L Puig
Immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients receiving secukinumab: a literature review. The Journal of dermatological treatment (2023)
Christian Ciolfi, Riccardo Balestri, Federico Bardazzi, Martina Burlando, Karin Chersi, Antonio Costanzo, Paolo Dapavo, Paolo Gisondi, Piergiorgio Malagoli, Miriam Pizzolato, Giulia Rech, Francesco Paolo Russo, Sara Battistella, Stefano Piaserico
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: a multicentric retrospective cohort study of 49 patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Francesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, Stefano Piaserico, Clara De Simone, Giovanni Damiani, Giuseppe Argenziano, Marina Venturini, Paolo Dapavo, Antonio Costanzo, Matteo Megna, Francesca Prignano, Martina Burlando, Francesca Satolli, Andrea Carugno, Elena Pezzolo, Marco Romanelli, Aldo Cuccia, Giampiero Girolomoni
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study. Vaccines 11 (4) (2023)
Marina Talamonti, Filomena Russo, Giovanna Malara, Katharina Hansel, Manuela Papini, Angelo Cattaneo, Aurora Parodi, Andrea Chiricozzi, Piergiorgio Malagoli, Federico Bardazzi, Valeria Brazzelli, Paolo Dapavo, Paolo Gisondi, Cristina Zane, Concetta Potenza, Franca Cantoresi, Maria-Concetta Fargnoli, Sara Trevisini, Pina Brianti, Leonardo Pescitelli, Giovanni Gigante, Marta Bartezaghi, Luisa Caputo, Elisabetta Aloisi, Antonio Costanzo, null null
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study. Clinical, cosmetic and investigational dermatology 16 (2023)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2023)
Marie Aleth Richard, Carle Paul, Tamar Nijsten, Paolo Gisondi, Carmen Salavastru, Charles Taïeb, Alex Stratigos, Myrto Trakatelli, Lluis L Puig, null null
The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Paolo Gisondi, Lluis L Puig, Marie Aleth Richard, Carle Paul, Tamar Nijsten, Charles Taïeb, Alex Stratigos, Myrto Trakatelli, Carmen Salavastru, null null
Quality of life and stigmatization in people with skin diseases in Europe: A large survey from the 'burden of skin diseases' EADV project. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Martina Maurelli, Paolo Gisondi, Francesco Bellinato, Alessandro Mantovani, Giovanni Targher, Giampiero Girolomoni
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis. Journal of clinical medicine 12 (18) (2023)
Francesco Bellinato, Paolo Gisondi, Annunziata Dattola, A G Richetta, Antonio Costanzo, Mario Valenti, Clara De Simone, Angelo Valerio Marzano, M Zussino, Elena Pezzolo, M Nacca, Giovanni Pellacani, Giampiero Girolomoni
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2023)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2023)
Marie Aleth Richard, Pierre Wolkenstein, Carle Paul, Tamar Nijsten, Paolo Gisondi, Carmen Salavastru, Charles Taïeb, Myrto Trakatelli, Lluis L Puig, Alex Stratigos, null null
Ethnicity and skin conditions in Europe: a large survey from the "Burden of Skin Diseases" EADV project. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Advanced Glycation End Products and Psoriasis. Vaccines 11 (3) (2023)
Tiago Torres, Jordi Galván, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Paolo Gisondi, Y José Manuel Carrascosa, Bruno Halioua, Anthony Bewley, Andreas Pinter
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review. Dermatology and therapy (2023)
Michela Magnano, Riccardo Balestri, Paolo Gisondi, F Bardazzi, V Di Lernia, T Ioris, C R Girardelli, G Rech
Biologics in psoriatic patients with malignancies: where are we now? An Italian multicentric study. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Giampiero Girolomoni, Laura Savage, Paolo Gisondi, Åke Svensson, Emmanuel Mahé, Matthias Augustin, Lluis L Puig
Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review. Dermatology and therapy (2023)
Marie Aleth Richard, Carle Paul, Tamar Nijsten, Paolo Gisondi, Carmen Salavastru, Charles Taïeb, Myrto Trakatelli, Lluis L Puig, Alex Stratigos, null null
Public perception of dermatologists in Europe: Results from a population-based survey. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Maria-Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, Paolo Dapavo, Gabriella Fabbrocini, Paolo Gisondi, Giuseppe Micali, Anna Maria Offidani, Giovanni Pellacani, Nevena Skroza, Rosa Giuseppa Angileri, Martina Burlando, Campanati Anna, Carlo Giovanni Carrera, Andrea Chiricozzi, Andrea Conti, Clara De Simone, Vito Di Lernia, Enzo Errichetti, Marco Galluzzo, Claudio Guarneri, Claudia Lasagni, Serena Lembo, Francesco Loconsole, Matteo Megna, Maria Letizia Musumeci, Francesca Prignano, Antonio Giovanni Richetta, Emanuele Trovato, Marina Venturini, Ketty Peris, Piergiacomo Calzavara Pinton
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement. Journal of clinical medicine 12 (10) (2023)
Francesco Bellinato, Paolo Gisondi, Guido Mioso, Elena Mason, Danny Straiotto, Stefano Piaserico, Giampiero Girolomoni
The transition from mild to moderate-to-severe chronic plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Advanced Glycation End Products and Psoriasis. Vaccines 11 (3) (2023)
Rebecca Favaro, Alessandra Formai, Giulia Pavia, Luigi Gargiulo, Jessica Avagliano, Mario Valenti, Paola Facheris, Beatrice Salsano, Roberta Valeria Latorre, Francesco Bellinato, Paolo Gisondi, Alessandra Narcisi, Antonio Costanzo
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV2 infection and vaccination. The British journal of dermatology (2023)
Lidia Sacchelli, Federica Filippi, Anna Balato, Riccardo Balestri, Francesco Bellinato, Nicoletta Bernardini, L Bianchi, Martina Burlando, Campanati Anna, Marco Adriano Chessa, M Corazza, Antonella Di Cesare, V Di Lernia, F Diotallevi, Maria Esposito, Maria-Concetta Fargnoli, Paolo Gisondi, Alessandro Giunta, Katharina Hansel, Michela Magnano, Matteo Megna, Giulia Odorici, Francesca Prignano, C Potenza, G Rech, M Rovesti, Ruggiero Angelo, F Satolli, Luca Stingeni, Dino Gibertoni, F Bardazzi
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Francesco Bellinato, Paolo Gisondi, Guido Mioso, Elena Mason, Danny Straiotto, Stefano Piaserico, Giampiero Girolomoni
The transition from mild to moderate-to-severe chronic plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Francesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, Stefano Piaserico, Clara De Simone, Giovanni Damiani, Giuseppe Argenziano, Marina Venturini, Paolo Dapavo, Antonio Costanzo, Matteo Megna, Francesca Prignano, Martina Burlando, Francesca Satolli, Andrea Carugno, Elena Pezzolo, Marco Romanelli, Aldo Cuccia, Giampiero Girolomoni
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study. Vaccines 11 (4) (2023)
Francesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, Stefano Piaserico, Clara De Simone, Giovanni Damiani, Giuseppe Argenziano, Marina Venturini, Paolo Dapavo, Antonio Costanzo, Matteo Megna, Francesca Prignano, Martina Burlando, Francesca Satolli, Andrea Carugno, Elena Pezzolo, Marco Romanelli, Aldo Cuccia, Giampiero Girolomoni
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study. Vaccines 11 (4) (2023)
Francesco Bellinato, Paolo Gisondi, Anna Balato, Giacomo Caldarola, Edoardo Cammarata, Elena Campione, Andrea Carugno, Andrea Conti, Monica Corazza, Paolo Dapavo, Annunziata Dattola, Vito Di Lernia, Massimo Gasperini, Salvatore Panduri, Francesca Prignano, Francesca Satolli, Enzo Spisni, Giampiero Girolomoni
Awareness of obesity among patients with psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Francesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, Stefano Piaserico, Clara De Simone, Giovanni Damiani, Giuseppe Argenziano, Marina Venturini, Paolo Dapavo, Antonio Costanzo, Matteo Megna, Francesca Prignano, Martina Burlando, Francesca Satolli, Andrea Carugno, Elena Pezzolo, Marco Romanelli, Aldo Cuccia, Giampiero Girolomoni
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study. Vaccines 11 (4) (2023)
Christian Ciolfi, Riccardo Balestri, Federico Bardazzi, Martina Burlando, Karin Chersi, Antonio Costanzo, Paolo Dapavo, Paolo Gisondi, Piergiorgio Malagoli, Miriam Pizzolato, Giulia Rech, Francesco Paolo Russo, Sara Battistella, Stefano Piaserico
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Davide Geat, Paolo Gisondi, Martina Maurelli, Lluis L Puig, Carle Paul, Diamant Thaçi, Lars Iversen, Francesco Bellinato, Giampiero Girolomoni
Price variability of TNF-α inhibitor biosimilars among European countries. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Martina Burlando, Gabriella Fabbrocini, Claudio Marasca, Paolo Dapavo, Andrea Chiricozzi, Dalma Malvaso, Valentina Dini, Campanati Anna, Annamaria Offidani, Annunziata Dattola, Raffaele Dante Caposiena Caro, Luca Bianchi, Marina Venturini, Paolo Gisondi, Claudio Guarneri, Giovanna Malara, Caterina Trifirò, Piergiorigio Malagoli, Maria-Concetta Fargnoli, Stefano Piaserico, Luca Carmisciano, Riccardo Castelli, Aurora Parodi
Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study. Biomedicines 10 (10) (2022)
Andrea Chiricozzi, Francesco Bellinato, Paolo Romita, Paolo Gisondi
Psoriasis: talking points from recent clinical trials. Expert opinion on investigational drugs 31 (12) (2022)
Kristina Callis Duffin, Luis Daniel Mazzuoccolo, María Julia Cura, Maria Esposito, Anthony P Fernandez, Paolo Gisondi, Alessandro Giunta, Tom M Hillary, Stefano Piaserico, James A Solomon, Joseph Frank Merola
Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of rheumatology (2022)
Katie Bechman, Emma S Cook, Nick Dand, Zenas Zee Ngai Yiu, Teresa Tsakok, Freya Meynell, Bolaji Coker, Alexandra Vincent, Herve Bachelez, Ines Barbosa, Matthew A Brown, Francesca Capon, Claudia R Contreras, Claudia De La Cruz, Paola Di Meglio, Paolo Gisondi, Denis Jullien, Jade Kelly, Jo Lydie Wilfried Lambert, Camille Lancelot, Sinéad M Langan, Kayleigh J Mason, Helen McAteer, Lucy Moorhead, Luigi Naldi, Katherine Jones, Lluis L Puig, Phyllis I Spuls, Tiago Torres, Dominic Urmston, Amber Vesty, Richard Bruce Warren, Hoseah Waweru, John Weinman, Christopher Ernest Maitland Griffiths, Jonathan N W N Barker, Catherine H Smith, James B Galloway, Satveer K Mahil, null null
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey. The British journal of dermatology 187 (2) (2022)
Paolo Gisondi, Francesco Bellinato, Martina Maurelli, Davide Geat, Alen Zabotti, Dennis McGonagle, Giampiero Girolomoni
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis. Psoriasis (Auckland, N.Z.) 12 (2022)
Andrea Chiricozzi, Francesco Bellinato, Paolo Romita, Paolo Gisondi
Psoriasis: talking points from recent clinical trials. Expert opinion on investigational drugs (2022)
Paolo Gisondi, Davide Geat, Francesco Bellinato, Giampiero Girolomoni
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis. Expert opinion on biological therapy (2022)
Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study. Vaccines 10 (8) (2022)
Paolo Gisondi, Davide Geat, Patrizio Armeni, Francesco Bellinato, Martina Maurelli, Giampiero Girolomoni
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis. Expert opinion on biological therapy (2022)
Andrea Chiricozzi, Francesco Bellinato, Paolo Romita, Paolo Gisondi
Psoriasis: Talking points from recent clinical trials. Expert opinion on investigational drugs (2022)
Francesco Bellinato, Paolo Gisondi, Giampiero Girolomoni
Monkeypox virus infection: what dermatologist needs to know? Journal of the European Academy of Dermatology and Venereology : JEADV 36 (8) (2022)
Paolo Gisondi, Martina Maurelli, Francesco Bellinato, Giampiero Girolomoni
Is risankizumab as needed administration a good option for patients with plaque psoriasis? Journal of the European Academy of Dermatology and Venereology : JEADV 36 (9) (2022)
Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni
Skin adverse reactions to Sars-CoV-2 vaccination: a relevant responsibility issue for dermatologists. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (2) (2022)
F Bardazzi, Federica Filippi, M A Chessa, M Iommi, C Loi, Campanati Anna, Giulio Rizzetto, C Tagliati, Laura Atzori, S Muratori, Giovanni Genovese, Paolo Gisondi, D Schena, Riccardo Balestri, G Rech, Claudio Feliciani, C Lasagni, L Bigi, C De Simone, G Di Zenzo, F Moro, Alessandro Borghi, V Di Lernia, G D'Arrigo, G Tripepi, M Gori, A Pitino
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (12) (2022)
Francesco Bellinato, Zeno Fratton, Giampiero Girolomoni, Paolo Gisondi
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis. Vaccines 10 (9) (2022)
Andrea Chiricozzi, Francesco Bellinato, Paolo Romita, Paolo Gisondi
Psoriasis: talking points from recent clinical trials. Expert opinion on investigational drugs 31 (12) (2022)
Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Tailored biological treatment for patients with moderate-to-severe psoriasis. Expert review of clinical immunology (2022)
Paolo Gisondi, Davide Geat, Martina Maurelli, Luca Degli Esposti, Francesco Bellinato, Giampiero Girolomoni
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease. Vaccines 10 (5) (2022)
Francesco Bellinato, Andrea Chiricozzi, Stefano Piaserico, Giovanni Targher, Paolo Gisondi
Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis? International journal of molecular sciences 23 (21) (2022)
Francesco Bellinato, Maria Gaia Mastrosimini, Giulia Querzoli, Paolo Gisondi, Giampiero Girolomoni
Dupilumab for recalcitrant Kimura disease. Dermatologic therapy 35 (9) (2022)
Ulrich Mrowietz, Jonathan Barker, Curdin Conrad, Denis Jullien, Paolo Gisondi, Andrea Flower, Jyotsna Reddy, Maria Paris, Hernan Picard, Shauna Jardon, Matthias Augustin
Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Martina Maurelli, Francesco Bellinato, Paolo Gisondi, Giampiero Girolomoni
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (8) (2022)
Marie Aleth Richard, C Paul, T Nijsten, Paolo Gisondi, C Salavastru, Charles Taïeb, M Trakatelli, Lluis L Puig, A Stratigos, null null
Prevalence of most common skin diseases in Europe: a population-based study. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (7) (2022)
Paolo Gisondi, M Maurelli, A Costanzo, M Esposito, G Girolomoni
The Combination of Dupilumab with Other Monoclonal Antibodies. Dermatology and therapy (2022)
S K Mahil, M Yates, S M Langan, Z Z N Yiu, T Tsakok, N Dand, Kayleigh J Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, Herve Bachelez, I N Bruce, Francesca Capon, C R Contreras, A P Cope, C De La Cruz, Paola Di Meglio, Paolo Gisondi, K Hyrich, D Jullien, J Lambert, H Marzo-Ortega, I McInnes, L Naldi, S Norton, Lluis L Puig, R Sengupta, P Spuls, Tiago Torres, R B Warren, H Waweru, J Weinman, C E M Griffiths, J N Barker, M A Brown, J B Galloway, C H Smith, null null
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey. The British journal of dermatology 185 (1) (2021)
Stefano Piaserico, Andrea Conti, Francesco Messina, Alberto Meneguzzo, Giulia Odorici, Francesco Bellinato, Paolo Gisondi
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (4) (2021)
Simone Garcovich, Martina Maurelli, Paolo Gisondi, Ketty Peris, Gil Yosipovitch, Giampiero Girolomoni
Pruritus as a Distinctive Feature of Type 2 Inflammation. Vaccines 9 (3) (2021)
Francesco Bellinato, Paolo Gisondi, Martina Maurelli, Giampiero Girolomoni
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review. Dermatologic therapy 34 (2) (2021)
Paolo Gisondi, Davide Geat, Francesco Bellinato, Laura Spiazzi, Elisa Danese, Martina Montagnana, Gian Luca Salvagno, Giampiero Girolomoni
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis. Journal of personalized medicine 11 (11) (2021)
Paolo Gisondi, Giampiero Girolomoni
Undertreatment in adult patients with moderate-to-severe atopic dermatitis and other chronic inflammatory skin diseases. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (10) (2021)
Paolo Gisondi, Francesco Bellinato, Giovanni Targher, Luca Idolazzi, Giampiero Girolomoni
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis. Annals of the rheumatic diseases (2021)
Paolo Gisondi, Sara Di Leo, Francesco Bellinato, Simone Cazzaniga, Stefano Piaserico, Luigi Naldi
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review. Dermatology and therapy 11 (3) (2021)
Maria Esposito, Alessandro Giunta, Paolo Gisondi, Sara Tambone, Marco Rovaris, Valeria Manfreda, Federico Pirro, Cristina Pellegrini, Maria Concetta Fargnoli, Luca Bianchi, Ketty Peris, Giampiero Girolomoni
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study. Dermatologic therapy 34 (3) (2021)
Paolo Gisondi, D Geat, Luigi Naldi, Stefano Piaserico
Insights into Sars-CoV-2 vaccination in patients with chronic plaque psoriasis on systemic treatments. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (6) (2021)
Paolo Gisondi, Francesco Bellinato, Stefano Piaserico, Sara Di Leo, Simone Cazzaniga, Luigi Naldi
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs. Dermatology and therapy 11 (4) (2021)
Paolo Gisondi, Simone Cazzaniga, S Di Leo, Stefano Piaserico, Francesco Bellinato, M Pizzolato, A Gatti, A Eccher, M Brunelli, D Saraggi, Giampiero Girolomoni, L Naldi
Impact of the COVID-19 pandemic on melanoma diagnosis. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (11) (2021)
Francesco Bellinato, Paolo Gisondi, Giampiero Girolomoni
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules. Biologics : targets & therapy 15 (2021)
Paolo Gisondi, Davide Geat, Giampiero Girolomoni
Place of apremilast in the real-life treatment of patients with plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (1) (2021)
Francesco Bellinato, Martina Maurelli, Chiara Colato, Paolo Gisondi, Giampiero Girolomoni
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature. Clinical case reports 9 (6) (2021)
Stefano Piaserico, Paolo Gisondi, Simone Cazzaniga, Giampiero Girolomoni, P G Calzavara-Pinton, Luigi Naldi
Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? Journal of the European Academy of Dermatology and Venereology : JEADV 35 (6) (2021)
Jennifer Beecker, Kim A Papp, J Dutz, Ronald B Vender, Robert Gniadecki, Curtis L Cooper, Paolo Gisondi, Melinda J Gooderham, C H Hong, M G Kirchhof, C W Lynde, C Maari, Y Poulin, Lluis L Puig
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (4) (2021)
D Thaçi, Denis Jullien, Alexander Egeberg, Y José Manuel Carrascosa, J J Wu, I Pau-Charles, Paolo Gisondi
Low incidence rate of respiratory and viral infections over 5 years of treatment with tildrakizumab in patients with moderate-to-severe psoriasis: pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (11) (2021)
Francesco Bellinato, Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products. Clinical and experimental dermatology (2021)
Francesco Bellinato, Martina Maurelli, Paolo Gisondi, Giampiero Girolomoni
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines. Journal of clinical medicine 10 (22) (2021)
Tamar E C Nijsten, Jonathan Ian Silverberg, Paolo Gisondi, Christian L Vestergaard, Loes M Hollestein, M Wakkee
Considerations in association studies in dermatoepidemiology. The British journal of dermatology 185 (1) (2021)
Paolo Gisondi, Francesco Bellinato, Andrea Chiricozzi, Giampiero Girolomoni
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments. Vaccines 8 (4) (2020)
Maria-Concetta Fargnoli, M Esposito, P Dapavo, A Parodi, M Rossi, R Tiberio, S Dastoli, A M Offidani, G Argenziano, Paolo Gisondi, A Lo Schiavo, F Loconsole, P Pella, F Bardazzi, F Cusano, M Gattoni, M Nacca, S P Cannavò, C Pellegrini, Antonio Costanzo, null null
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (3) (2020)

Paolo Gisondi.css-eqlu8i{font-size:small;padding-left:4px;} (P Gisondi)

Publication Activity (10 Years)

Top Topics

Top Venues

Paolo Gisondi (P Gisondi)